Dan Mendelson: Selling The Device Is Not Enough
Executive Summary
In the current era, device developers must consider value, costs and bundling of their products to health-care buyers, not just securing fast approval from US FDA and a reimbursement decision from CMS, Avalere President Dan Mendelson writes in this guest column.